Actively Recruiting
Evaluation of the JUICE HA® as an Anti-sarcopenia
Led by China Medical University Hospital · Updated on 2026-02-27
60
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.
CONDITIONS
Official Title
Evaluation of the JUICE HA® as an Anti-sarcopenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants diagnosed with sarcopenia by a physician and meeting the AWGS 2019 criteria for sarcopenia
You will not qualify if you...
- History of severe lower extremity musculoskeletal injuries within the past six months
- Fear of blood sampling
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University Hospital
Taichung, Taiwan, 404327
Actively Recruiting
Research Team
C
Chih-Hsueh Lin, Medical Master Degree
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here